Note: Ingredients listed on restricted chemical lists
EC/CAS
26761-40-0
Name of the chemical
Di-iso-decyl phthalate(DIDP),5
Concentration
20-40
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-5
EC/CAS
64742-55-8
Name of the chemical
Distillates (petroleum), hydrotreated light paraffinic
Concentration
1-2.5
EC/CAS
1305-78-8
Name of the chemical
Calcium oxide
Concentration
N/A
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
0.1-1
General Information
Revision date
2018-01-31
Product name
Sakrete Polyurethane Self Leveling Sealant
1.2.1 Relevant identified uses
Sealant
Emergency telephone
1-800-424-9300, +1 703-527-3887
Icons in SDS
Company Information
company name
Sakrete of North America
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW DANGER MAY CAUSE RESPIRATORY SENSITIZATION. CORROSIVE MATERIAL - MAY CAUSE BURNS. MAY CAUSE CANCER.
Potential health effects
See Section 11 for more information
Principle Routes of Exposure
Skin contact, eye contact, inhalation, and ingestion Eye: Irritating to eyes. May cause burns. Skin: Irritating to skin. May cause burns. Ingestion: May cause burns. May be harmful if swallowed. May cause stomach distress, nausea or vomiting. Inhalation: May cause respiratory tract irritation. May cause respiratory sensitization.
Potential chronic health
Contains ingredients known or suspected to be carcinogenic. May cause sensitization by inhalation. Signs and Symptoms: Symptoms may include discomfort or pain, excess blinking and tear production, with possible redness and swelling. Symptoms may include redness, edema, drying, defatting and cracking of the skin. Cough, discomfort, difficulty breathing, or shortness of breath.
Medical Conditions Generally Aggravated by Exposure
Asthma. Allergies Target Organs: Skin, eyes, gastrointestinal tract, respiratory system.
Environmental effects
May cause long-term adverse effects in the aquatic environment. See Section 12 for more information.
